|
|
|
|
FOCUS ON UPSTREAM MANUFACTURING |
|
|
|
By Better Biopharma | Biotech leader Nicole Paulk, Ph.D., joins “Better Biopharma” to discuss Siren Biotechnology’s switch from plasmids to producer cell lines, CGT funding challenges, and the competition that determined which CDMO won Siren’s business. | |
|
|
|
|
|
|
|
|
|
|
| Rev-Up AAV Genome Production In Upstream Manufacturing | Application Note | By Becky Reese, Jennifer Swanson, Austin Storck and Laura Juckem, Mirus Bio | By increasing recombinant AAV titers, this AAV enhancer can help reduce upstream manufacturing costs and lower the cost per therapeutic dose. |
|
|
|
|
| Webinar: Next-Generation MSC Therapies: Advancing Treatment for GvHD | Join this Corning Life Sciences webinar to explore an innovative approach for enhancing mesenchymal stromal cell (MSC) therapy in graft-versus-host disease (GvHD). Learn how genetically engineered Ad-MSCs co-expressing CXCR4 and IL-10 demonstrated superior migration, immune modulation, and therapeutic benefit in preclinical models. Plus, discover how Corning® HYPER technology enables efficient GMP-scale production for clinical applications. Register now to secure your spot! Click here to learn more. |
|
|
UPSTREAM MANUFACTURING SOLUTIONS |
|
|
|
|
|
|
|
|
|
| Webinar: Cell Bank & Scale Up Strategies for MSC & Exosome Manufacturing | This webinar explores two key decisions affecting the manufacturability and long-term success of advanced therapies. RoosterBio experts will share strategies for reducing costs, risks, and timelines in GMP manufacturing through optimized cell banking. Attendees will learn about major risk areas, effective banking strategies, and scale-up techniques for MSC and exosome production to support clinical and commercial success. Register here. |
|
|
Connect With Bioprocess Online: |
|
|
|